Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Identify practical ways to prepare your budget for surprises through proactive adjustments and an emergency fund, strengthening your financial footing.
19,028 articlesCellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
ExxonMobil stock surged January as energy markets moved higher, but the real story runs deeper than a single month. T...
A clear, investor-friendly breakdown of Primoris' Q1 2026 earnings. Learn what drove results, how to read backlog and...
Investors tracking UiPath PATH know 2027 will hinge on cloud adoption, service expansion, and pricing power. This gui...
As rates stay elevated and markets shift, retirees are rethinking how to fund living costs without eroding the inheri...
CrowdStrike faced a sharp sell-off for a second consecutive day after a sector-wide reaction to new AI security produ...
Pinterest has shown strong quarterly results, yet the stock moves on mixed signals. This guide breaks down the what's...
Wintermute is stepping into the prediction-market arena by supplying liquidity on Kalshi and Polymarket, aiming to li...
What could SpaceX look like a century from now? This article examines long-term catalysts, scenarios, and real-world ...
Investors who want clarity from SPX Technologies can decode the SPXC earnings transcript. This guide translates the n...
Vericel faces a pivotal 2026 earnings season. This guide breaks down the drivers behind the numbers, what to watch in...
Nvidia sits at the crossroads of AI demand and high-performance computing. This article dives into why prediction: nv...